Kairos Archives - Kairos Ventures

Quicksilver Biosciences

By: Charissa On: September 28, 2023 In:

Quicksilver Biosciences is developing a rapid, point-of-care diagnostic tool that can identify a vast array of analytes with unprecedented...

CytoDel

By: Charissa On: December 8, 2022 In:

Mattiq

By: Charissa On: April 8, 2021 In:

Mattiq, formerly known as Stoicheia, promises to revolutionize the process of discovering new materials by deciphering the “materials genome.”

Vivodyne

By: Charissa On: April 8, 2021 In:

Vivodyne is changing how scientists study human biology & develop therapeutics. Their platform technology creates a new preclinical drug...

Actinia

By: Charissa On: February 26, 2021 In:

Actinia develops radiation detection solutions for medical imaging, nuclear energy applications, and non-proliferation of illicit radioactive materials.

Novosteo

By: Charissa On: November 23, 2020 In:

Quince Therapeutics, previously Cortexyme, is a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases. Cortexyme acquired...